Literature DB >> 7880240

Management of cancer of the prostate.

W J Catalona1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7880240     DOI： 10.1056/NEJM199410133311507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

2.  Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study.

Authors:  Fatma Al-Saeedi
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

3.  Unilateral proptosis: an unusual presentation of prostatic carcinoma.

Authors:  Anna Louise Pouncey; Thomas Peter Fox; Catherine Anne Bryant
Journal:  BMJ Case Rep       Date:  2013-05-27

Review 4.  Prostate cancer in the elderly.

Authors:  Hatzimouratidis Konstantinos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Detection of prostate cancer.

Authors:  F H Schröder
Journal:  BMJ       Date:  1995-01-21

Review 6.  Prostate cancer: 3. Individual risk factors.

Authors:  R P Gallagher; N Fleshner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 7.  Primary staging of prostate cancer.

Authors:  G J Jager; J O Barentz; E T Ruijter; J J de la Rosette; G O Oosterhof
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

8.  Screening for prostate cancer: estimating the magnitude of overdetection.

Authors:  M McGregor; J A Hanley; J F Boivin; R G McLean
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

Review 9.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer.

Authors:  R N Brogden; D Faulds
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

10.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.